Drug Database · Clinicians

Sacubitril

Brands (1) ValuzShow all

Angiotensin receptor-neprilysin inhibitor PH FDA category

Rx · Prescription drug1 PH product
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Sodium salt complex) film-coated tablet: 50 mg (eq. to Sacubitril 24.3 mg + Valsartan 25.7 mg

Registered products in the Philippines

1 product registered with the Food and Drug Administration (FDA) Philippines list Sacubitril as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Sacubitril
Package insert
ValuzSacubitril
50 mg (eq. to Sacubitril 24.3 mg + Valsartan 25.7 mg sodium salt complex) Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s)
Rx
Exemed PharmaceuticalsIndia
The Cathay YSS Distributors Co., Inc.Importer: AMB HK Enterprises Inc.
DRP-16448-05
Mar 18, 2030

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .